Onset of vitiligo in a patient with acquired secondary hypogonadism under treatment with testosterone gel 2%: inside the pathogenesis

An Bras Dermatol. 2020 Sep-Oct;95(5):661-662. doi: 10.1016/j.abd.2020.02.010. Epub 2020 Jul 15.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Hormone Replacement Therapy
  • Humans
  • Hypogonadism* / chemically induced
  • Hypogonadism* / drug therapy
  • Hypopigmentation*
  • Testosterone / adverse effects
  • Vitiligo* / chemically induced

Substances

  • Testosterone